The provided text contains detailed information related to The Procter & Gamble Company's financial statements, including summaries of earnings, comprehensive income, balance sheets, shareholders' equity, cash flows, segment information, goodwill, intangible assets, earnings per share, share-based compensation, risk management activities, fair value measurements, accumulated other comprehensive income/(loss), commitments, and contingencies. It also provides details on legal proceedings, income tax uncertainties, and various related financial data, giving a comprehensive overview of the company's financial status and operational activities.
The text delves into a company's forward-looking statements and risks, such as global financial risks, economic volatility, supply chain disruptions, and technological advancements. The Management's Discussion and Analysis highlights key aspects like organic sales growth, net earnings, and market performance across segments. The company faced challenges from costs, foreign exchange fluctuations, and government policies affecting financial performance, particularly amid the COVID-19 pandemic. Additionally, the financial performance details the fluctuations in segments like Beauty, Grooming, and Health Care, discussing net sales increases, savings, non-operating expenses, income taxes, and net earnings. Various factors like unit volume, pricing, mix, and foreign exchange impacts drove revenue and earnings changes across segments, impacting metrics like effective tax rate, net earnings margin, and operating income. Despite obstacles like foreign exchange impacts and changes in operating margin, improvements were seen in net earnings and earnings per share, with detailed breakdowns comparing results over specific periods for each segment.
No material changes have occurred in the Company's market risk exposure since June 30, 2021. Further details can be found in Note 7 of the Consolidated Financial Statements regarding Risk Management Activities and Fair Value Measurements.
The Company's President and Chief Executive Officer, Jon R. Moeller, and the Chief Financial Officer, Andre Schulten, evaluated the disclosure controls and procedures of the Company as per the Securities Exchange Act of 1934. They concluded that the disclosure controls and procedures were effective in ensuring timely and accurate information is disclosed in reports filed under the Exchange Act. There were no changes in internal controls over financial reporting during the fiscal quarter ended March 31, 2022, that materially affected the Company's internal control over financial reporting.
The text provided outlines the legal proceedings and claims that the Company is subject to from time to time, covering various areas such as antitrust, product liability, contracts, environmental issues, and more. However, for the specified period, there are no relevant matters to disclose under this item.
The text provides a reference to the risk factors section in the Company's Form 10-K for the year ended June 30, 2021. It directs readers to review this section for information on risk factors related to the company.
The text provided details the unregistered sales of equity securities and the use of proceeds by a company. It outlines the total number of shares purchased, average price paid per share, and the total number of shares purchased as part of publicly announced plans or programs over different periods. Additionally, it discusses the company's plans to reduce outstanding shares through direct share repurchases at a value of approximately $10 billion in fiscal year 2022, with purchases possibly being made in the open market or private transactions and financed by a combination of operating cash flows and issuance of long-term and short-term debt.
I'm ready to receive the text parts and provide you with a summary.
I am ready to receive the parts of the text whenever you are ready to send them.
I am ready to summarize the text for you. Please go ahead and provide me with the text.
The text provided consists of various exhibits and certifications related to a company's filings, as well as XBRL documents and information regarding short-term achievement reward programs. The mentioned items are part of the company's SEC filing, with references to regulations, certifications by executive officers, and various related exhibits. The document also includes dates and authorizations for the report signing. The Procter & Gamble Company is the entity making the disclosures, and the key focus appears to be on regulatory compliance and financial reporting transparency.
